206 related articles for article (PubMed ID: 9460281)
1. [Skin and mucous membrane hemorrhages: clinical assessment, study sequence and relative frequency of hereditary diseases of the hemostasis in a Chilean population].
Quiroga T; Pérez M; Rodríguez S; Muñoz B; Aranda E; Morales M; Verdugo P; Pereira J; Mezzano D
Rev Med Chil; 1997 Apr; 125(4):409-18. PubMed ID: 9460281
[TBL] [Abstract][Full Text] [Related]
2. [The clinical problem of hereditary hemorrhagic diseases developing prolonged bleeding time].
Bello A; Dorantes S; Enriqueta Zamudio M; Alvarez Amaya C; Killnee MS
Bol Med Hosp Infant Mex; 1975; 32(2):227-48. PubMed ID: 1079731
[TBL] [Abstract][Full Text] [Related]
3. Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: a definitive diagnosis is often not possible.
Pereira J; Quiroga T; Mezzano D
Semin Thromb Hemost; 2008 Oct; 34(7):654-62. PubMed ID: 19085766
[TBL] [Abstract][Full Text] [Related]
4. [The factor VIII complex: hemophilia A and von Willebrand disease].
Tobelem G; Rothschild C
Sem Hop; 1982 Sep; 58(35):2032-6. PubMed ID: 6293093
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls.
Quiroga T; Goycoolea M; Panes O; Aranda E; Martínez C; Belmont S; Muñoz B; Zúñiga P; Pereira J; Mezzano D
Haematologica; 2007 Mar; 92(3):357-65. PubMed ID: 17339185
[TBL] [Abstract][Full Text] [Related]
6. [Measurement of bleeding time and study of thrombocyte aggregation. Standardization of methods, normal values and results in patients with suspected hemorrhagic diathesis].
Thommen D; Sulzer I; Buhrfeind E; Naef R; Furlan M; Lämmle B
Schweiz Med Wochenschr; 1988 Oct; 118(43):1559-67. PubMed ID: 3238391
[TBL] [Abstract][Full Text] [Related]
7. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of Von Willebrand disease and inherited platelet function disorders amongst Indian bleeders.
Gupta PK; Charan VD; Saxena R
Ann Hematol; 2007 Jun; 86(6):403-7. PubMed ID: 17375300
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
Castaman G; Federici AB; Rodeghiero F; Mannucci PM
Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
[TBL] [Abstract][Full Text] [Related]
10. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
11. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
[TBL] [Abstract][Full Text] [Related]
13. Epidural analgesia for parturients with type 1 von Willebrand disease.
Marrache D; Mercier FJ; Boyer-Neumann C; Roger-Christoph S; Benhamou D
Int J Obstet Anesth; 2007 Jul; 16(3):231-5. PubMed ID: 17509867
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
[TBL] [Abstract][Full Text] [Related]
15. [Children with hemorrhagic diathesis: correct diagnostic and therapeutic approach].
Carnelli V; Dozzi M; Gibelli M; Giovanniello A; Riva F; Seidita C; Stucchi C
Pediatr Med Chir; 1990; 12(1):1-13. PubMed ID: 2198546
[TBL] [Abstract][Full Text] [Related]
16. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
Shihong I; Morris D; Konkle BA
Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
[TBL] [Abstract][Full Text] [Related]
17. The level of laboratory testing required for diagnosis or exclusion of a platelet function disorder using platelet aggregation and secretion assays.
Mezzano D; Quiroga T; Pereira J
Semin Thromb Hemost; 2009 Mar; 35(2):242-54. PubMed ID: 19408197
[TBL] [Abstract][Full Text] [Related]
18. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
[TBL] [Abstract][Full Text] [Related]
19. Inherited disorders of platelet function in pediatric clinical practice: a diagnostic challenge.
Streif W; Knöfler R; Eberl W
Klin Padiatr; 2010 May; 222(3):203-8. PubMed ID: 20514633
[TBL] [Abstract][Full Text] [Related]
20. Management of inherited von Willebrand disease.
Mannucci PM; Federici AB
Best Pract Res Clin Haematol; 2001 Jun; 14(2):455-62. PubMed ID: 11686109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
